Bristol-Myers Squibb Co (BMY)

Add to Watchlists
Create an Alert
Quickflows
66.54 +0.52  +0.79% NYSE Jan 15, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All BMY News

News

View All Events

Events

Date Type Description
02/04/2021 Earnings Bristol-Myers Squibb Co Fourth Quarter Earnings Result for 2020
02/04/2021 08:30 EST Misc Bristol-Myers Squibb Co Fourth Quarter Earnings Conference Call for 2020
12/31/2020 Dividends Amount: 0.49, Declared Date: Dec 10 2020, Pay Date: Feb 01 2021
11/05/2020 Earnings Bristol-Myers Squibb Co Third Quarter Earnings Result for 2020
11/05/2020 08:30 EST Misc Bristol-Myers Squibb Co Third Quarter Earnings Conference Call for 2020
10/01/2020 Dividends Amount: 0.45, Declared Date: Sep 10 2020, Pay Date: Nov 02 2020
08/06/2020 08:30 EDT Misc Bristol-Myers Squibb Co Second Quarter Earnings Conference Call for 2020
08/06/2020 Earnings Bristol-Myers Squibb Co Second Quarter Earnings Result for 2020
07/02/2020 Dividends Amount: 0.45, Declared Date: Jun 12 2020, Pay Date: Aug 03 2020
05/07/2020 08:30 EDT Misc Bristol-Myers Squibb Co First Quarter Earnings Conference Call for 2020
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 39.40B
Total Expenses (TTM) 35.82B
Net Income (TTM) -44.00M

Balance Sheet View Statement

Total Assets (Quarterly) 125.54B
Total Liabilities (Quarterly) 75.31B
Shareholders Equity (Quarterly) 50.16B

Cash Flow Statement View Statement

Cash from Operations (TTM) 12.42B
Cash from Investing (TTM) -10.77B
Cash from Financing (TTM) -12.31B

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.bms.com
  • Investor Relations URL: N/A
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Feb. 04, 2021
  • Last Earnings Release: Nov. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Dec. 31, 2020
  • Description: Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 66.54
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
VGHCX Vanguard Health Care Inv 4.23%
XLV Health Care Select Sector SPDR® ETF 3.42%
HDV iShares Core High Dividend ETF 2.73%
VHT Vanguard Health Care ETF 2.65%
OIEFX JPMorgan Equity Income R2 2.21%
DODGX Dodge & Cox Stock 1.64%
VDADX Vanguard Dividend Appreciation Index Adm 1.53%
VIG Vanguard Dividend Appreciation ETF 1.53%
DGRO iShares Core Dividend Growth ETF 1.41%
VHYAX Vanguard High Dividend Yield Index Adm 1.27%
VYM Vanguard High Dividend Yield ETF 1.27%
FISRX Franklin Income R 0.92%

Comparables

Edit
AMGN Amgen Inc
JNJ Johnson & Johnson
LLY Eli Lilly and Co
MRK Merck & Co Inc
PFE Pfizer Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.